TO THE EDITOR
Kindler syndrome (KS) (OMIM 173650) is a rare autosomal recessive genodermatosis characterized by trauma-induced blistering, poikiloderma, and varying degrees of photosensitivity (Kindler 1954) . Over 50 cases of KS have been reported although clinical heterogeneity is well recognized (Ashton et al., 2004) . The gene responsible for KS, KIND1, encodes a 677-aminoacid protein called kindlin-1 (previously also known as kindlerin), which is involved in linking the actin cytoskeleton to focal contacts (Jobard et al., 2003; Siegel et al., 2003) . Loss of kindlin-1 in keratinocytes has recently been shown to lead to decreased cell adhesion, reduced proliferation, increased apoptosis, and loss of cell polarity (Herz et al., 2006) . KS therefore represents the first inherited skin disorder to result from primary defects in the actin cytoskeleton/focal contacts and, thus far, 25 different mutations in KIND1 in individuals with KS have been published, most of which lead to loss of KIND1 mRNA and kindlin-1 protein expression (Jobard et al., 2003; Siegel et al., 2003; Ashton et al., 2004; Has and Bruckner-Tuderman (2004) ; Fassihi et al., 2005; Sethuraman et al., 2005; Thomson et al., 2006; Has et al., 2006; Burch et al., 2006; Sadler et al., 2006) . Collectively, however, these mutations do not readily explain the clinical heterogeneity seen in KS and a paradigm for genotype-phenotype correlation is still lacking. In this report, therefore, we describe five new homozygous mutations in individuals with KS and assess these and the previously published KIND1 mutations to explore further the clinical implications of determining KIND1 mutations in this unusual genodermatosis.
Case 1 is a 15-year-old Indian male born to consanguineous parents ( Figure  1a-c) . He developed recurrent episodes of generalized blistering, which later became confined to his hands and feet. He also suffered from photosensitivity with marked poikiloderma of sun-exposed areas beginning at 5 years of age. His skin was atrophic particularly on the dorsal aspect of the hands and feet. His palmoplantar skin showed diffuse waxy thickening and his nails were dystrophic. In addition, he had chronic gingivitis and urethral stenosis. His 12-year-old sister had similar skin and oral abnormalities (Figure 1d) .
Case 2 is a 30-year-old Indian male born to consanguineous parents (unrelated to case 1). He developed acral blisters during infancy and followed by progressive skin atrophy with poikiloderma. He developed photosensitivity from the age of 8 years and suffered with gingival bleeding, which improved in adulthood. He also suffered from dysphagia and urethral stenosis but had no nail dystrophy.
Case 3 is a 30-year-old Somalian male born to consanguineous parents. His clinical features consisted of acral blistering in childhood and generalized but mild ichthyosis. He also had acral keratoses, fused web spaces and suffered from photosensitivity since early childhood. Further, he had small erosions scattered on his trunk and extremities and his gingival mucosa bled easily. One of his brothers, now deceased, had similar clinical features.
Case 4 is a 15-year-old South African male of Indian ancestry born to nonconsanguineous but geographically linked parents. He had a single selflimiting episode of blistering on his left heel at birth. Thereafter, he developed progressive and marked skin atrophy on the dorsae of his hands and feet with occasional fissuring. Poikiloderma affecting the face, arms and legs was evident. He developed photosensitivity that started in infancy but which improved in adolescence. In addition, he had chronic gingivitis since childhood, which was associated with easily bleeding gums and marked dental caries. There were no other mucosal disease or nail abnormalities.
Case 5 is a 3-year-old Indian female born to consanguineous parents (not related to case 1 or 2). She developed acral blistering 10 days after birth. Her skin was atrophic, especially on the dorsal aspects of her hands and feet. She had progressive poikiloderma, which started at the age of 1 year and affected her neck, face, and extremities. She suffered with easily bleeding gums and rectum (related to anal fissure). Nails were normal.
Blood sampling and KIND1 gene analysis were performed following ethical committee approval from Guy's and St Thomas' Hospital. Written informed consent was obtained from each individual patient and the study was conducted according to Declaration of Helsinki Principles. PCR amplification of genomic DNA was carried out using 14 pairs of primers spanning the coding exons and flanking introns of the KIND1 gene, as described elsewhere (Siegel et al., 2003; Ashton et al., 2004) . The PCR products were purified using a QIAquick PCR purification kit (Qiagen, Crawley, UK) and sequenced in an ABI 310 genetic analyzer (Applied Biosystems, Warrington, UK).
Each subject with KS was homozygous for a novel single nucleotide substitution in KIND1 (Figure 2a) , resulting in either a nonsense mutation (cases 1, 4, and 5) or a splice site mutation (cases 2 and 3). The mutations comprised case 1 p.E168X, case 2 IVS13 þ 1G4A, case 3 IVS14-1G4C, case 4 p.S114X, and case 5 p.E516X. None of these mutations was identified in screening 100 ethnically matched control chromosomes. When added to previous molecular studies in KS, 30 different pathogenic mutations in KIND1 have been documented. These consist of 12 nonsense, 11 frameshift, six splice site mutations, and one Alu/Alu recombination-associated internal deletion. Of these, nine mutations have been reported in more than one family, either as propagated ancestral alleles (IVS7-1G4A, p.E304X, p.W616X, c.1161delA, g.70250_74168del, c.373delT) or as recurrent mutations in diverse ethnic groups (c.676insC, p.R271X, p.R288X) (Ashton et al., 2004; Has et al., 2006) .
Each of the new homozygous mutations we identified is predicted to produce a truncated kindlin-1 protein and/or low levels of mRNA expression. Clinically, however, there does not appear to be any clear correlation between the site or nature of the mutations and the specific features of the disease. In these five individuals with KS, there was considerable variability in clinical features such as presence or absence of urethral involvement or dysphagia or nail dystrophy as well as the degree of photosensitivity, the onset of the poikiloderma, or the extent of the gingival fragility. These differences may partly be explained by the different ages at which the cases were assessed because many of the clinical features or complications of KS only manifest with time. In addition, the diverse ethnic and geographical backgrounds of the cases studied may also have an impact on (a) In case 1, there is a homozygous G4T transversion at nucleotide c.502 changing a glutamic acid codon (GAG) to a stop codon (TAG), designated p.E168X. In case 2, there is homozygous donor splice site mutation within intron 13, IVS13 þ 1G4A. In case 3, there is a homozygous acceptor splice site mutation within intron 14, IVS14-1G4C. In case 4, there is a homozygous C4G transversion at nucleotide c.341, converting a serine residue (TCA) to a stop codon (TGA), designated p.S114X. In case 5, there is a homozygous G4T transversion at nucleotide c.1546 causing replacement of a glutamic acid (GAG) codon by a stop codon (TAA), designated p.E516X.
(b) The current database of KIND1 mutations is shown, including the five new mutations identified in this study (highlighted in purple text).
www.jidonline.org 2269 phenotype. Moreover, review of the published mutation reports in KS demonstrates widespread clinical heterogeneity even for individuals with identical KIND1 mutations and the same ethnicity. For example, the homozygous mutation c.676insC, which has been reported in 11 individuals from seven families of Pakistani origin (with either similar or different KIND1 haplotypes), has been associated with poikiloderma and blistering in all subjects but with varying degrees of chronic gingivitis and skin atrophy (Ashton et al., 2004; Thomson et al., 2006) . Likewise, intra-and interfamilial heterogeneity in the KS phenotype is also evident for the recurrent homozygous KIND1 mutations p.E304X and p.R271X. In some cases, environmental factors such as the degree of sun exposure or oral trauma might account for some of the phenotypic diversity. For example, individuals from Panama and Oman who are homozygous for the mutation p.R271X tend to have an earlier onset of photosensitivity and poikiloderma compared with subjects from the USA harboring the same homozygous nonsense mutation in KIND1 (Siegel et al., 2003; Penagos et al., 2004) . Moreover, these Panamanian cases with KS usually have less gingival inflammation in early life, which may reflect a relatively later introduction of a solid diet. Another variable clinical feature is squamous cell carcinoma which has been described in four cases of KS (Lotem et al., 2001; Ashton et al., 2004; Has et al., 2006; Emanuel et al., 2006) , two of whom had known KIND1 mutations (Ashton et al., 2004; Has et al., 2006) . The squamous cell carcinomas developed between the ages of 34 and 57 years but as most of the KIND1 mutation database involves individuals younger than this (including the five cases in our report) there is currently insufficient data to correlate KIND1 mutations with the risk of mucocutaneous malignancy in KS. In summary, analysis of the clinical features present in our new cases of KS and the previously published reports reveal that blistering, poikiloderma, photosensitivity, skin atrophy, and periodontal inflammation are common features but there are no obvious phenotypic differences resulting from the various nonsense, frameshift, deletion, or splice site mutations in KIND1. As far as genetic counseling is concerned, delineation of pathogenic mutations in KIND1 is very useful in making an early diagnosis of KS , but, unlike mutational analysis in other blistering genodermatoses such as dystrophic epidermolysis bullosa that results from mutations in the COL7A1 gene, the nature of the KIND1 mutations in KS does not have much value in predicting the clinical course and potential complications of the disease. Other environmental exposures as well as currently unknown genetic or epigenetic factors may have a significant impact on phenotypic expression in KS.
